The three generic players namely, Dr. Reddy, Par pharma and Teva Pharma has got final approval from USFDA on September 9, 2009 to market Nateglinide (Starilax) 60 mg and 120 mg tablets.
The generic launch was possible after the expiry of product patent USRE34878, which expired on Sep 8, 2009
Earlier, Innovator Novartis got final approval to market Nateglinide (Starilax) 60 mg and 120 mg tablets on December 22, 2000.
The approved generic versions are AB rated w.r.t Starilax tablets
No comments:
Post a Comment